This is a non-blinded randomized screening trial of asymptomatic singleton pregnancies without prior spontaneous preterm birth who are randomized to either transvaginal ultrasound cervical length screening program (i.e. intervention group) or no screening (i.e. control group). Women are consented and randomized at the time of their routine anatomy scan between 18 0/7 and 23 6/7 weeks. Women randomized in the transvaginal ultrasound cervical length screening will receive a single transvaginal ultrasound cervical length measurement after the anatomy scan. The cervical length will be measured by operators with certification of competence in the technique.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
1,334
transvaginal ultrasound cervical length
Gabriele Saccone
Naples, Italy
RECRUITINGSeconda Università di Napoli Luigi Vanvitelli
Napoli, Italy
RECRUITINGpreterm birth rate
either spontaneous or indicated preterm delivery
Time frame: Less than 37 weeks
preterm birth rate
either spontaneous or indicated preterm delivery
Time frame: ess than 24, 28, 32, 30, and 34 weeks gestation
admission to neonatal intensive care unit
Time frame: time of delivery
neonatal death
Time frame: Between birth and 28 days of age
birth weight
weight of the baby at the time of delivery
Time frame: time of delivery
Composite of adverse perinatal outcomes
Number of neonates who will have at least one of the following: necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death
Time frame: Between birth and 28 days of age
perinatal death
either fetal or neonatal mortality
Time frame: Between birth and 28 days of age
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.